Changes in Beneficial Ownership · 4
Prestige Consumer Healthcare Inc.
PBHNYSEEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
tm2622318-2_4seq1.xml
Filing details
- Report period
- 2026-08-04
- Issuer
- Prestige Consumer Healthcare Inc.
- Issuer CIK
- 0001295947
- Trading symbol
- PBH
Reporting owner 1
- Name
- Clark Celeste A.
- Reporting owner CIK
- 0001261319
- Relationship
- Director
- Address
- 660 WHITE PLAINS ROAD, TARRYTOWN, NY, 10591
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.01 per share | 2026-08-04 | A · Form 4 | 2,981[F1] | A | 0 | 16,511 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- The Reporting Person received 2,981 restricted stock units equal to $155,000 divided by the closing stock price of $52.00 on August 4, 2026, in connection with the Issuer's director compensation program. The restricted stock units vest on the first anniversary of grant and will be settled by delivery to the Reporting Person of one share of common stock of the issuer for each vested restricted stock unit promptly following the earliest of (1) the Reporting Person's death, (ii) the Reporting Person's separation or (iii) change in control.↩ 1
Signature 1
- Signed
- /s/ Celeste Clark by Christine Sacco Attorney-in-Fact pursuant to Power of Attorney dated May 4, 2021on file with the Commission
- Date
- 2026-08-05
Company context
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Breathe Right® nasal strips, Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Current securities
Recent company filings
- 10-Q filingNov 5, 2026
- Results of Operations and Financial Condition · Regulation FD DisclosureNov 5, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsAug 14, 2026
- 10-Q filingAug 6, 2026
- Results of Operations and Financial Condition · Regulation FD DisclosureAug 6, 2026